ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Dr. Reddy’s Bachupally plant experiences a version of FDA deja vu fiercepharma
February 24, 2019A Dr. Reddy’s formulation plant in India appears stuck on regulatory repeat. The drugmaker reported that the FDA had completed an inspection of the facility in Bachupally and cited it with 11 violations. When the FDA inspected the plant in 2017 it?was cit
Pharma Sources Insight July 2025
